Showing results (71-80 of 371) with videos related to
Sort By:
Pageof 38
Oncology|March 1, 1996
Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinomaG Anastassiou, S Duensing, G Steinhoff, et al.Journal of Neuroscience Research|June 16, 1999
SNAP-25 requirement for dendritic growth of hippocampal neuronsG Grosse, J Grosse, R Tapp, et al.Human Molecular Genetics|August 19, 2003
A mouse model for cystinuria type IT Peters, C Thaete, S Wolf, et al.Cytokines and Molecular Therapy|March 1, 1995
Lymphocyte-conditioned medium in combination with interleukin-2 effectively induces antitumour autoimmunity by adoptive transfer of short activated killer (SHAK) cellsJ Buer, R Hilse, I Dallmann, et al.Der Anaesthesist|May 29, 2007
[Central induction area. Reduction of non-operative time without additional costs]H Krieg, T Schröder, J Grosse, et al.Oncology|July 1, 1994
Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patientsS Duensing, I Dallmann, J Grosse, et al.Anticancer Research|January 1, 1995
In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2M Meffert, A Schomburg, E L Hänninen, et al.Invasion & Metastasis|January 1, 1996
Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell lineS Duensing, F Brevis Nunez, N Meyer, et al.Physical Review Letters|April 8, 2011
Circular dichroism in biological photonic crystals and cubic chiral netsM Saba, M Thiel, M D Turner, et al.Cancer Biotherapy|January 1, 1994
In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2M Meffert, E L Hanninen, T Menzel, et al.Pageof 38